Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review

MLA

Efstratios Maltezos, et al. “Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review.” Current Vascular Pharmacology, vol. 11, Jan. 2014, pp. 992–1000. EBSCOhost, https://doi.org/10.2174/15701611113119990103.

APA

Efstratios Maltezos, Vasilis Tsimihodimos, Evangelos C. Rizos, Moses Elisaf, Zoi Mitrogianni, Nikolaos Papanas, & Evangelia E. Ntzani. (2014). Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review. Current Vascular Pharmacology, 11, 992–1000. https://doi.org/10.2174/15701611113119990103

Chicago

Efstratios Maltezos, Vasilis Tsimihodimos, Evangelos C. Rizos, Moses Elisaf, Zoi Mitrogianni, Nikolaos Papanas, and Evangelia E. Ntzani. 2014. “Combination Therapies of DPP4 Inhibitors and GLP1 Analogues with Insulin in Type 2 Diabetic Patients: A Systematic Review.” Current Vascular Pharmacology 11 (January): 992–1000. doi:10.2174/15701611113119990103.